PDLIM2 and uterine carcinosarcoma: The results showed that PDLIM2 expression was significantly associated with immune checkpoint expression in most tumor types, although there was no significant relationship in ACC, esophageal carcinoma, LIHC, uterine carcinosarcoma, and uveal melanoma (Fig. 8).